ArticleThe oncologist2025

Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.

Ferdinandos Skoulidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.